A perspective,open-label,and multi-center phase Ⅱ study of FOLFOX 4 regimen as systemic therapy for patients with unresectable hepatocellular carcinoma
GONG Xin-lei
QIN Shu-kui
WANG Ya-jie
XING Bao-cai
WU Qing
CAO Meng-ran
HUA Hai-qing
LIU Xiu-feng
Machine-generated Keywords：
Publication Date：2011-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)